Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Operating Income 2010-2023 | MKGAF

Merck annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Merck operating income for the quarter ending December 31, 2023 was $0.667B, a 26.18% decline year-over-year.
  • Merck operating income for the twelve months ending December 31, 2023 was $3.907B, a 17.11% decline year-over-year.
  • Merck annual operating income for 2023 was $3.907B, a 17.11% decline from 2022.
  • Merck annual operating income for 2022 was $4.714B, a 4.64% decline from 2021.
  • Merck annual operating income for 2021 was $4.943B, a 44.97% increase from 2020.
  
Merck Annual Operating Income
(Millions of US $)
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly Operating Income
(Millions of US $)
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $20.162B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.564B 27.36
Chugai Pharmaceutical (CHGCY) Japan $54.745B 23.77
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Astellas Pharma (ALPMY) Japan $17.246B 24.44
Sandoz Group AG (SDZNY) Switzerland $14.663B 0.00
Shionogi (SGIOY) Japan $14.423B 12.48
Neurocrine Biosciences (NBIX) United States $13.300B 55.23
United Therapeutics (UTHR) United States $11.015B 11.80
Catalent (CTLT) United States $10.144B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.644B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.856B 6.95
Revolution Medicines (RVMD) United States $6.000B 0.00
Ionis Pharmaceuticals (IONS) United States $5.986B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.248B 0.00
Alpine Immune Sciences (ALPN) United States $4.233B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.023B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.964B 0.00
Evotec AG (EVO) Germany $2.608B 0.00
Indivior (INDV) United States $2.556B 11.89
Summit Therapeutics (SMMT) United States $2.449B 0.00
Corcept Therapeutics (CORT) United States $2.321B 23.47
Dyne Therapeutics (DYN) United States $2.143B 0.00
PTC Therapeutics (PTCT) United States $1.990B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.809B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.806B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.783B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.782B 18.42
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.649B 9.76
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.567B 0.00
Ardelyx (ARDX) United States $1.515B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.262B 11.85
Soleno Therapeutics (SLNO) United States $1.219B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Collegium Pharmaceutical (COLL) United States $1.136B 6.99
Xencor (XNCR) United States $1.113B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.003B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.909B 0.00
Cronos Group (CRON) Canada $0.902B 0.00
Cassava Sciences (SAVA) United States $0.887B 0.00
USANA Health Sciences (USNA) United States $0.851B 13.40
Enliven Therapeutics (ELVN) United States $0.825B 0.00
ARS Pharmaceuticals (SPRY) United States $0.792B 0.00
Ocular Therapeutix (OCUL) United States $0.785B 0.00
Relay Therapeutics (RLAY) United States $0.781B 0.00
Sage Therapeutics (SAGE) United States $0.775B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Silence Therapeutics (SLN) United Kingdom $0.673B 0.00
Savara (SVRA) United States $0.649B 0.00
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Siga Technologies (SIGA) United States $0.594B 8.79
Verve Therapeutics (VERV) United States $0.578B 0.00
Korro Bio (KRRO) United States $0.549B 0.00
OmniAb (OABI) United States $0.548B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.539B 0.00
Altimmune (ALT) United States $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.483B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.417B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.392B 74.25
Heron Therapeutics (HRTX) United States $0.389B 0.00
Harrow (HROW) United States $0.375B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.43
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Bioventus (BVS) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Fractyl Health (GUTS) United States $0.313B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.284B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nanobiotix S.A (NBTX) France $0.270B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Black Diamond Therapeutics (BDTX) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.254B 0.00
Metagenomi (MGX) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Foghorn Therapeutics (FHTX) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.211B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.149B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.144B 0.00
Elite Pharmaceuticals (ELTP) United States $0.136B 12.72
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Relmada Therapeutics (RLMD) United States $0.117B 0.00
OptiNose (OPTN) United States $0.116B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Inotiv (NOTV) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.089B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Carisma Therapeutics (CARM) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.80
MEI Pharma (MEIP) United States $0.022B 1.13
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.81